We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Aconitase Plays Two Roles in Cellular Metabolism

By Biotechdaily staff writers
Posted on 21 Feb 2005
Researchers have found that aconitase, the enzyme in the Kreb's cycle that converts citrate to isocitrate, plays an important role in maintaining the integrity of the DNA that makes up the mitochondrial genome.

The mitochondrial genome in humans comprises 37 genes. More...
Twenty-four of the genes specify RNA molecules involved in protein synthesis while the remaining 13 encode proteins required for the biochemical reactions that make up respiration. A number of rare diseases are caused by mutations in mitochondrial DNA, and the tissues primarily affected are those that most rely on respiration, i.e., the brain and nervous system, muscles, and the kidneys and liver. All mitochondrial diseases are maternally inherited, since all the mitochondria in the developing human embryo come from the egg. There are no mitochondria in the sperm head, which carries the paternal half of the nuclear genome.

Investigators at the University of Texas Southwestern Medical Center (Dallas, USA) worked with a yeast model to study the behavior of aconitase. They found that the enzyme's catalytic activity was separate from its function in DNA maintenance. As aconitase is manufactured in the cytoplasm and then transported into the mitochondria, the investigators speculated that it might be part of the cell's retrograde signaling network. These findings were published in the February 4, 2005, edition of Science.

"Mitochondrial DNA was discovered in the 1960s, and we still do not know much about how it is organized, packaged, or inherited,” said senior author Dr. Ronald Butow, professor of molecular biology at the University of Texas Southwestern Medical Center. "What is really amazing is that we very recently discovered proteins associated with mitochondrial DNA that were thought to only have metabolic functions, and that aconitase, one of these proteins, is essential for mitochondrial DNA maintenance and inheritance, a new function independent of its normal enzyme activity.”




Related Links:
University of Texas Southwestern Medical Center

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.